AtaiBeckley (ATAI) Other Accumulated Expenses (2021 - 2026)
AtaiBeckley's (ATAI) quarterly Other Accumulated Expenses came in at $179000.0 in Q1 2026, down 93.14% quarter-over-quarter from $2.6 million in Q4 2025.
AtaiBeckley (ATAI) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
AtaiBeckley's Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $179000.0 for Q1 2026.
- On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $179000.0 in Q1 2026; TTM through Mar 2026 was $179000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2.6 million, up 386.03% from the prior year.
- Other Accumulated Expenses fell to $179000.0 in Q1 2026 per ATAI's latest filing, from $2.6 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q3 2024 to a low of $8000.0 in Q3 2021.
- A 5-year average of $605312.5 and a median of $556500.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Biggest YoY gain for Other Accumulated Expenses was 386.03% in 2025; the steepest drop was 386.03% in 2025.
- Year by year, Other Accumulated Expenses stood at $537000.0 in 2024, then jumped by 386.03% to $2.6 million in 2025, then plunged by 93.14% to $179000.0 in 2026.
- Per Business Quant, the three latest ATAI Other Accumulated Expenses figures stand at $179000.0 (Q1 2026), $2.6 million (Q4 2025), and $537000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | AtaiBeckley | 1.56 Bn | 1.56 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179,000.00 |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 487,000.00 |
| Jun 30, 2025 | 421,000.00 |
| Mar 31, 2025 | 576,000.00 |
| Dec 31, 2024 | 537,000.00 |
| Dec 31, 2024 | 537,000.00 |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 877,000.00 |
| Sep 30, 2023 | 463,000.00 |
| Jun 30, 2023 | 890,000.00 |
| Mar 31, 2023 | 795,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | 958,000.00 |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | 227,000.00 |
| Dec 31, 2021 | 163,000.00 |
| Sep 30, 2021 | 8,000.00 |